Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Treating gonorrhea today

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Gonorrhea treatment has narrowed steadily over decades as the bacterium developed resistance to one antibiotic class after another. What is left is a single injection.

That is why the details matter more than they used to: the right drug, the right dose, by injection, with partners treated and a retest afterwards.

Related pages: Gonorrhea

The bottom line

What we know
  • Ceftriaxone by intramuscular injection is first-line.
  • Azithromycin is no longer routinely co-administered.
  • Doxycycline is added when chlamydia has not been excluded.
  • Alternative regimens exist for allergy and are less well studied.
What is still open
  • How long ceftriaxone will remain reliable.
  • Which new agents in development will reach clinical use.

The story, step by step

  1. 1. The standard ()
  2. 2. What changed ()
  3. 3. Allergy and alternatives ()
  4. 4. Special situations ()
  5. 5. Resistance ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

One injection

Review of many studies

What happens

What first-line treatment is now.

What the research shows

  • A single intramuscular dose of ceftriaxone. The dose is weight-based, with a higher dose for people above a weight threshold.
  • It is an injection rather than tablets because oral cephalosporins no longer reliably cure gonorrhea, particularly in the throat.
  • Doxycycline for seven days is added when chlamydia has not been excluded, because co-infection is common and chlamydia needs separate treatment.
  • If chlamydia testing is negative, doxycycline is not needed for the gonorrhea itself.
  • Treatment is often given at the same visit as testing when symptoms are present, rather than waiting for results.

Why it matters

There is no oral-only treatment for gonorrhea in current guidance. If someone is offering tablets alone, that is out of date.

What's still uncertain

  • Weight-based dosing is based on pharmacokinetic modelling rather than large outcome trials.

Read more

Next: What changed

Part 2 of 5

Azithromycin dropped

Review of many studies

What happens

A significant change that many people and some sources have not caught up with.

What the research shows

  • For years the standard was ceftriaxone plus azithromycin together, on the theory that two drugs would slow resistance.
  • Guidance changed: azithromycin is no longer routinely added for gonorrhea.
  • The reasons were rising azithromycin resistance in gonorrhea and concern about driving resistance in other organisms, alongside evidence that ceftriaxone alone was sufficient at an adequate dose.
  • Doxycycline replaced it in the regimen, but for a different purpose: covering chlamydia rather than treating gonorrhea.
  • This matters practically because older advice circulating online still describes the two-drug regimen.

Why it matters

If a source recommends ceftriaxone plus azithromycin for gonorrhea, it predates the current guidance.

What's still uncertain

  • Whether single-drug treatment accelerates cephalosporin resistance is being monitored.

Read more

Next: Allergy and alternatives

Part 3 of 5

When ceftriaxone is not an option

Review of many studies

What happens

What is used instead, and why it is second best.

What the research shows

  • A true severe allergy to cephalosporins is uncommon, and many people labelled penicillin-allergic can safely receive ceftriaxone. Allergy assessment is worth asking about.
  • Where ceftriaxone genuinely cannot be used, alternative regimens exist, typically combining gentamicin with azithromycin, or using other agents.
  • These alternatives have lower cure rates, particularly for throat infections, which is why a test of cure is recommended after them.
  • Allergy should be described precisely: a rash in childhood is a different matter from an anaphylactic reaction, and the distinction changes the options.
  • Specialist advice is reasonable where options are limited.

Why it matters

A vague penicillin allergy label is worth clarifying before it narrows your treatment options, here and for the rest of your life.

What's still uncertain

  • Evidence for alternative regimens is considerably thinner than for ceftriaxone.

Read more

Next: Special situations

Part 4 of 5

Pregnancy, throat, spread

Review of many studies

What happens

Where treatment differs.

What the research shows

  • Pregnancy: gonorrhea is treated, and treated promptly, because untreated infection can cause preterm birth and can pass to the baby during delivery. Doxycycline is not used in pregnancy; azithromycin is used instead where chlamydia cover is needed.
  • Throat infections are harder to cure, which is why a test of cure 7 to 14 days after treatment is recommended for them.
  • Pelvic inflammatory disease and epididymitis need longer combination antibiotic courses rather than a single dose.
  • Disseminated gonococcal infection, where the bacteria spread to the blood, joints and skin, is treated in hospital with intravenous antibiotics.
  • Eye infection in adults needs urgent treatment, because it can damage sight quickly.
  • Newborn eye infection is a medical emergency and is why antibiotic eye ointment is given routinely at birth.

Why it matters

A single injection is the treatment for uncomplicated infection. Complications need more, which is why spreading symptoms are a reason to go back.

What's still uncertain

  • Optimal regimens for complicated infections are based on limited trial data.

Read more

Next: Resistance

Part 5 of 5

Why stewardship matters here

Review of many studies

What happens

The background that shapes all of the above.

What the research shows

  • Neisseria gonorrhoeae has developed resistance to sulphonamides, penicillin, tetracyclines and fluoroquinolones in turn. Each was once first-line.
  • Cephalosporins are the last widely effective class, and strains with reduced susceptibility have been reported in several countries, including a small number of extensively resistant cases.
  • The throat is thought to be where resistance develops most readily, because gonorrhea there is exposed to antibiotics given for other infections and can exchange genetic material with related bacteria.
  • This is why incomplete or incorrect treatment matters beyond the individual: it selects for resistance.
  • New antibiotics are in development, and several have reached late-stage trials. None is yet in routine use.
  • Surveillance programmes track resistance and are what guide changes in treatment recommendations.

Why it matters

The practical version: take the treatment as given, treat partners, and do not self-medicate. That is the stewardship part a person can actually do.

What's still uncertain

  • How quickly resistance will spread is not predictable.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.